FirmaIQ
Org.nr 983 644 600 2019 → 2020 Year-over-year analysis

CYTOVATION ASA: årsregnskap 2020 vs 2019

Weaker earnings, cash halved-plus

approved 2021-09-06; registry 2021-09-27; journal 2021 743683

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2020 with 2019 for CYTOVATION ASA. Net result -24.02m NOK → -37.70m NOK. Equity -10.32m NOK → -10.01m NOK.

On the constructive side: equity strengthened; owners injected capital. Pressures included: operating result weakened; net result weakened; cash fell.

Also worth watching: thin equity buffer; sharp cash drawdown. All figures are taken from the published annual accounts for CYTOVATION ASA.

At a glance

Scorecard

Operating result
-23.40m NOK -36.94m NOK
-57.9%
Net result
-24.02m NOK -37.70m NOK
-57.0%
Equity
-10.32m NOK -10.01m NOK
+3.0%
Cash
15.54m NOK 1.01m NOK
-93.5%
Total assets
20.57m NOK 5.81m NOK
-71.8%

What improved

  • ↑

    Equity strengthened

    Book equity -10.32m NOK → -10.01m NOK (equity ratio -50.2% → -172.5%). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 180.0k NOK → 194.3k NOK (+14.3k NOK). Reported fact

What deteriorated

  • ↓

    Operating result weakened

    Operating result -23.40m NOK → -36.94m NOK. Calculated

  • ↓

    Net result weakened

    Net result -24.02m NOK → -37.70m NOK. Calculated

  • ↓

    Cash fell

    Bank deposits 15.54m NOK → 1.01m NOK (-93.5% YoY). Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is -172.5% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation

  • ·

    Sharp cash drawdown

    Cash fell by more than 60% YoY (15.54m NOK → 1.01m NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation